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Abstract
The Protein Kinase Inhibitor (Pki) gene family inactivates nuclear PKA and terminates PKA-
induced gene expression. We previously showed that Pkig is the primary family member
expressed in osteoblasts and that Pkig knockdown increases the effects of parathyroid hormone
and isoproterenol on PKA activation, gene expression, and inhibition of apoptosis. Here, we
determined whether endogenous levels of Pkig regulate osteoblast differentiation. Pkig is the
primary family member in MEFs, murine marrow-derived mesenchymal stem cells, and human
mesenchymal stem cells. Pkig deletion increased forskolin-dependent nuclear PKA activation and
gene expression and Pkig deletion or knockdown increased osteoblast differentiation. PKA
signaling is known to stimulate adipogenesis; however, adipogenesis and osteogenesis are often
reciprocally regulated. We found that the reciprocal regulation predominates over the direct effects
of PKA since adipogenesis was decreased by Pkig deletion or knockdown. Pkig deletion or
knockdown simultaneously increased osteogenesis and decreased adipogenesis in mixed
osteogenic/adipogenic medium. Pkig deletion increased PKA-induced expression of Leukemia
Inhibitory Factor (Lif) mRNA and LIF protein. LIF neutralizing antibodies inhibited the effects on
osteogenesis and adipogenesis of either Pkig deletion in MEFs or PKIγ knockdown in both murine
and human mesenchymal stem cells. Collectively, our results show that endogenous levels of Pkig
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reciprocally regulate osteoblast and adipocyte differentiation and that this reciprocal regulation is
mediated in part by LIF.
Keywords
Protein kinase inhibitor; osteogenesis; adipogenesis; Leukemia Inhibitory Factor; mesenchymal
stem cell
Introduction
The cAMP/Protein Kinase A (PKA) signaling pathway is activated by Gαs–coupled
receptors and potently regulates multiple cellular processes. Because of the importance of
this pathway, its activity is precisely controlled by the interaction of multiple mechanisms
(1–4), including inactivation of PKA by the Protein Kinase Inhibitor (Pki) gene family (5–
8). We previously showed that inactivation of nuclear PKA by PKIγ is a primary mechanism
that reduces PKA signaling induced by Gαs–coupled receptors in mesenchymal cells (9, 10).
Consequently, inactivation of nuclear PKA by Pkig reduces PKA-dependent activation of
transcription factors and the resultant expression of rapidly and transiently induced mRNAs
(9, 10). There have been extensive and elegant investigations of the biochemistry and
structure of the PKI family and of the inactivation of PKA by PKI overexpression (5–8), but
prior to our studies (9–11), there were only two publications that showed effects of
endogenous PKI expressed at physiological levels (12, 13). In this regard, genetic deletion
of the other two members of the Pki family, either separately or in combination, caused little
detectable phenotype in the resultant mice because of compensatory regulation by other
components of the PKA pathway (14, 15).
PKA signaling stimulates bone formation due to effects on the osteoblast lineage, including
increased proliferation and differentiation of osteoblast precursors, activation of quiescent
lining cells, and prevention of apoptosis (16, 17). We previously showed that inactivation of
nuclear PKA by PKIγ is a primary mechanism that reduces the anti-apoptotic effects of
Gαs–coupled receptors in osteoblasts (11). Moreover, overexpression of PKIγ was reported
to reduce BMP2-induced osteoblast differentiation (18). One of the goals of the current
study was therefore to determine whether endogenous PKIγ, expressed at physiological
levels, reduces PKA-induced osteoblast differentiation.
Adipocyte differentiation is also stimulated by PKA signaling (19–22) and therefore might
be expected to be reduced by PKIγ. However, despite the preponderance of evidence that
PKA signaling stimulates adipocyte differentiation (19–22), there are also reports that PKA
signaling can have the opposite effect (23–26). As such, timing and magnitude of the PKA
signal may be important and the effects of PKI may be complex. It is also unknown whether
the direct effects of PKA on adipocyte differentiation will predominate over the reciprocal
regulation of adipocyte and osteoblast differentiation that frequently occurs because both
lineages differentiate from the same mesenchymal precursor cells (27, 28). Examples of
reciprocal regulation that are particularly relevant to the current study are the reduction of
adipocyte differentiation and stimulation of osteoblast differentiation in response to PKA
activation by forskolin (29), parathyroid hormone (PTH) (30, 31), or transgenic expression
of constitutively active PTH receptors (32). The second goal of this study was therefore to
determine whether endogenous PKIγ, expressed at physiological levels, stimulates or
reduces adipocyte differentiation and to resolve whether the direct effects of PKA
predominate over effects due to the reciprocal regulation of adipocyte and osteoblast
differentiation.
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Leukemia inhibitory factor (LIF), a member of the IL6 family of gp130-dependent
cytokines, can stimulate osteoblast differentiation (33–38) and reduce adipocyte
differentiation (34, 37, 39, 40). We previously found that Lif is one of the mRNAs that are
rapidly and transiently induced by PKA signaling in osteoblasts in cell culture and in vivo
(41–43). The third goal of this study was therefore to determine whether downregulation of
LIF expression by PKIγ mediates regulation of osteoblast and adipocyte differentiation.
Methods
Murine Embryonic Fibroblasts (MEFs)
Pkig−/− mice generated in our lab were backcrossed with C57BL/6J mice for four
generations. Wild type and Pkig−/− mice were obtained by breeding of the resultant Pkig+/−
mice and MEFs were prepared from embryos 12.5 to 13.5 days postcoitum using standard
techniques (44). MEFs were maintained in growth medium consisting of α-MEM medium
(SH30265.01, HyClone, Logan, UT) supplemented with 10% fetal bovine serum
(SH30071.03, HyClone), 2 mM L-glutamine (25-005-Cl, Cellgro, Manassas, VA), non-
essential amino acids (25-025-Cl, Cellgro), 100 units/ml penicillin and 100 ug/ml
streptomycin (30-002-Cl, Cellgro). For experiments, MEFs that had been passaged less than
five times were plated at 1×104/cm2 in growth medium.
Osteoblast differentiation by MEFs was induced as previously described (45). Briefly,
confluent MEFs were incubated in osteogenic medium consisting of the growth medium
supplemented with 50 ug/ml 2-phospho-L-ascorbic acid (49752, Sigma-Aldrich, St. Louis,
MO) and 10 mM β-glycerophosphate (G-9891, Sigma-Aldrich) plus 1 uM forskolin
(344270, Calbiochem, Gibbstown, NJ) or 0.1% DMSO as a vehicle control with medium
changes every 3 or 4 days. Specificity of the effects of forskolin was confirmed by showing
that the inactive analogue, dideoxy-forskolin (46), does not induce osteoblast differentiation
(Supplementary Figure 1). Indicated cultures also received 20% conditioned medium from
CHO cells that stably express BMP4, a kind gift from Dr. Tatsuya Koike, Osaka City
University Medical School (47, 48). The ability of this conditioned medium to stimulate
osteoblast differentiation is shown in Supplementary Figure 2.
Adipocyte differentiation was induced by incubating two day post-confluent MEFs with
multiple cycles of three days in induction medium and one day in maintenance medium as
described (49). The maintenance medium was the growth medium supplemented with 10 ug/
ml insulin (I5500, Sigma-Aldrich). The induction medium was the maintenance medium
further supplemented with 1 uM dexamethasone (D8893, Sigma-Aldrich), either 200 uM
indomethacin (I7378, Sigma-Aldrich) or 0.4% ethanol, and either 0.5 mM 3-isobutyl-1-
methylxanthine (IBMX, I701, Sigma-Aldrich) or 0.1% DMSO.
To simultaneously induce both osteoblast and adipocyte differentiation, confluent MEFs
were incubated with a 1:1 mixture of the osteogenic and adipogenic induction media as
recommended (49, 50). For this purpose, the adipogenic induction medium described above
was supplemented with both indomethacin and IBMX, but neither forskolin nor BMP4 was
added to the osteogenic medium. Media were changed every 3 or 4 days.
Murine marrow-derived Mesenchymal Stem Cells (mdMSCs)
The mdMSC cell line was obtained from bone marrow of adult male C57BL/6 mice and was
previously described (51). mdMSCs were maintained in the same growth medium described
above for MEFs. For reverse transfection, 5×104 mdMSCs in 1 ml of growth medium were
added to individual wells of a 12-well plate containing 200 pmoles of murine Pkig siRNA
(Dharmacon On-TARGET plus J-049150-10, Thermo Scientific, Waltham, MA) or non-
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targeting siRNA (Dharmacon D-001810-10-20, Thermo Scientific) that had been pre-
incubated for 30 minutes at room temperature with DharmaFECT 3 transfection reagent
(T-2003-03, Thermo Scientific) and DharmaFECT cell culture reagent (B-004500-100,
Thermo Scientific). Transfection reagents were replaced with growth medium after four
hours of incubation at 37°C in 5% CO2. Twenty hours later, mdMSCs were incubated with a
1:1 mixture of the osteogenic and adipogenic media previously described for these cells (51)
further supplemented with 0.25 mM IBMX. Media were changed every 3 days.
Human Mesenchymal Stem Cells (hMSCs)
The hMSCs were obtained from Lonza (PT-2501, Walkersville, MD) and maintained in
growth medium consisting of DMEM/high glucose medium (SH30243.01, HyClone)
supplemented with 10% fetal bovine serum, 2 mM L-glutamine, non-essential amino acids,
100 units/ml penicillin and 100 ug/ml streptomycin. For reverse transfection, 4×104 hMSCs
in 400 ul of growth medium were added to individual wells of a 24-well plate containing
100 pmoles of human PKIG siRNA (Dharmacon On-TARGET plus J-017218-06, Thermo
Scientific) or non-targeting siRNA that had been pre-incubated as described in the previous
paragraph. Transfection reagents were replaced with growth medium after four hours of
incubation at 37°C in 5% CO2. Twenty hours later, the hMSCs were then used in osteogenic
or adipogenic experiments. Osteogenic medium consisted of the growth medium
supplemented with 50 ug/ml 2-phospho-L-ascorbic acid and 10 mM β-glycerophosphate and
was changed every 3 days. Adipocyte differentiation was induced by 3 cycles of 3 days of
adipogenic induction medium (growth medium supplemented with 5 ug/ml insulin, 100 nM
dexamethasone, 50 uM indomethacin, and 0.5 mM IBMX) and 2 days of adipogenic
maintenance medium (growth medium supplemented with 5 ug/ml insulin) as recommended
by the manufacturer.
Quantitative real-time RT-PCR
Gene expression was measured by quantitative real-time RT-PCR using the linear portion of
standard curves as we previously described (52). All PCR primers were designed to overlap
exon-exon junctions at their 3′-termini using primer3 software (53) except for Pkig and
those mRNAs that are encoded by a single exon (Gapdh and C/ebpa). All primers were
validated by sequencing of PCR amplicons. Murine and human primers are listed in
Supplementary Table 1 and Supplementary Table 2, respectively. All assays included
negative controls without RNA, analysis of melting curves, and agarose gel electrophoresis
to confirm the presence of single PCR amplicons.
PKA activity assay
Nuclear fractions were prepared as we previously described (10). PKA activities were
assayed using fluorescently labeled-kemptide as substrate (Nonradioactive PepTag Assay
kit, V5340, Promega, Madison, WI). The fraction of phosphorylated kemptide was
quantified by measuring fluorescence (excitation at 535 nm and emission at 600 nm) on a
4000MM In-Vivo F Image Station (Kodak, Rochester, NY) after separation from non-
phosphorylated kemptide by electrophoresis on 0.8% agarose gels in Tris-Cl (pH 8.0) buffer.
>90% of kemptide phosphorylation by nuclear fractions from forskolin-treated MEFs is
inhibited by PKIα (Supplementary Figure 3) and is therefore due to PKA activity. PKA
activity was expressed as umol/min/ug protein. Total protein was measured using the BCA
protein assay kit (23227, Pierce, Rockford, IL).
Western blotting
MEFs were lysed in SDS sample buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS, and 10%
glycerol) plus protease inhibitors (cocktail tablet 04693159001, Roche, Mannheim,
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Germany) and phosphatase inhibitors (1 mM sodium pyrophosphate, 1 mM sodium
orthovanadate, and 1 mM β-glycerophosphate). Equivalent amounts of protein (BCA protein
assay) per lane were electrophoresed on 12% Tris-Glycine gels (59503, Lonza, Rockland,
ME) and transferred to PVDF membranes. Membranes were blocked in Tris-buffered saline
(pH 8.0) containing 0.05% Tween 20 and 5% non-fat dry milk and incubated with 1:1000
dilutions of primary antibody (pSer133-CREB, 9191; CREB, 9197; ATF4, 11815; β-actin,
4970; or GAPDH, 2118; all from Cell Signaling, Danvers, MA) or with 1:500 dilutions of
primary antibody (Runx2, 5356-1, Epitomics, Burlingame, California; or Osterix, ab22552,
Abcam, Cambridge, MA). The membranes were then incubated with horseradish
peroxidase-conjugated anti-rabbit IgG (Cell Signaling, 7074). Bands were detected by
chemiluminescence (Amersham ECL Plus, RPN2132, GE Health Care, Piscataway, NJ).
Alkaline phosphatase, Alizarin Red S, and Oil Red O assays
Alkaline phosphatase activity was measured biochemically as previously described (54).
Alkaline phosphatase staining was performed using a kit (86C-1KT, Sigma-Aldrich)
following the recommendations of the manufacturer. Staining of mineralization with
Alizarin Red S (A5533, Sigma-Aldrich) was performed and quantified following extraction
with 10% cetylpyridinium chloride as previously described (55). Staining of lipid
accumulation with Oil Red O (O0625, Sigma-Aldrich) was performed and quantified
following extraction with isopropanol as previously described (56). For co-staining, alkaline
phosphatase staining was performed first and the cells were then rinsed with water twice
before the Oil Red O staining.
LIF ELISA and neutralizing antibodies
LIF protein in cell culture supernatants was measured using a kit (MLF00, R & D Systems)
following the recommendations of the manufacturer. To determine whether LIF mediates
the effects of Pkig deletion or knockdown, indicated concentrations of either a neutralizing
affinity-purified goat anti-murine LIF antibody (AF449, R & D Systems, Minneapolis, MN)
or a normal goat control immunoglobulin (AB-108-C, R & D Systems) was incubated with
MEFs or mdMSCs experiments. To determine whether LIF mediates the effects of PKIG
knockdown, 10 ug/ml of either a neutralizing mouse anti-human LIF monoclonal antibody
(MAB250, R & D Systems) or an isotype control mouse IgG2B (MAB004, R & D Systems)
was incubated with hMSCs.
Statistical analysis
Unless otherwise indicated, all quantitative data are expressed as mean ± SD of three
independent experiments, each containing triplicate culture wells assayed in triplicate.
Statistical analysis was by Student’s t-test for experiments with two groups and by One Way
ANOVA with Bonferroni post hoc tests of the indicated comparisons for experiments with
three or more groups. All statistical tests were performed with SigmaStat 3.0 software
(Systat Software, Inc, Point Richmond, CA). P values less than 0.05 were considered
statistically significant. All non-quantitative results were also derived from three
independent experiments. Images from representative experiments were selected based on
the results from the quantitative portions of the same experiments. For example, the images
in Figure 1C are from the experiment that was closest to the means in Figure 1B.
Results
Pkig deletion increases PKA signaling
Pkig mRNA is the dominant Pki family member expressed in osteoblasts and other
mesenchymal cells (6, 10). Consistent with those findings, Pkig mRNA expression is 3.8-
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fold higher than Pkia mRNA expression in wild type MEFs and Pkib mRNA is barely
detectable (first three groups in Fig. 1A). We previously showed that Pkig knockdown by
either siRNA or antisense approaches substantially increases PKA signaling (10, 11). To
determine whether off-target effects might be responsible for the effects of Pkig knockdown,
we compared wild type and Pkig−/− MEFs. Pkig deletion does not induce detectable
compensatory changes in mRNAs encoding either of the other PKI family members (last
three groups in Fig. 1A). Pkig deletion substantially increases the magnitude and extends the
time course of both nuclear PKA activation and phosphorylation of CREB and ATF1
transcription factors induced by forskolin in MEFs (Figs. 1B–C). Similarly, Pkig deletion
substantially increases stimulation by forskolin of c-fos, Lif, and IL6 mRNAs (Figs. 1D–F).
Taken together, these results demonstrate that PKA signaling is increased by Pkig deletion
in MEFs. They therefore confirm our previous studies of Pkig knockdown (10, 11) and
validate MEFs as a cellular model system for investigating the effects of Pkig deletion.
Pkig deletion increases osteoblast differentiation
PKA signaling induced by the adenylate cyclase activator forskolin stimulates osteoblast
differentiation in vitro (29, 48, 57). To examine whether the enhanced PKA signaling
induced by Pkig deletion also increases osteoblast differentiation, we took advantage of the
ability of MEFs to model MSCs by undergoing osteoblastic differentiation (45, 58–61) as
well as adipocytic and chondrocytic differentiation (62, 63). In osteogenic medium, Pkig
remains the dominant Pki family member expressed in MEFs and Pkig deletion does not
induce detectable compensatory changes in the other Pki family members (Figs. 2A–C). The
transcription factors, Runx2 and osterix were expressed at high levels by both wild type and
Pkig−/− MEFs at the beginning of the culture period at both the mRNA (1st group in Figs.
2D–E) and protein levels (Supplementary Figure 4). Runx2 and osterix mRNA levels
decreased in the wild type MEFs during culture (red symbols in Figs. 2D–E) but remained
elevated in the Pkig−/− MEFs (blue symbols in Figs. 2D–E). As expected, ATF4 was
induced during osteoblast differentiation and was modestly increased at the mRNA level by
Pkig deletion at day 7 (Fig. 2F).
Alkaline phosphatase was used as a marker of the middle stage of osteoblast differentiation.
Culture in osteogenic medium containing forskolin increases alkaline phosphatase mRNA
levels (red symbols in Fig. 2G). Pkig deletion further increases forskolin-induced alkaline
phosphatase mRNA levels by 3.7 and 5.3-fold respectively after three and seven days (blue
symbols in Fig. 2G). As expected, for a late stage marker of osteoblast differentiation,
osteocalcin mRNA levels are only modestly affected after three days of incubation in
osteogenic medium containing forskolin (middle pair of groups in Fig. 2H). However, Pkig
deletion increases osteocalcin mRNA levels by 16.5-fold after seven days (last pair of
groups in Fig. 2H).
To confirm the effects observed on the mRNA markers, alkaline phosphatase activity and
mineralization were assessed. These experiments were conducted in the absence and
presence of BMP4 because osteoblast differentiation induced by BMPs is enhanced by
forskolin (48, 57) and blocked by PKIγ overexpression (18). Forskolin increases alkaline
phosphatase activity and mineralization both in the absence and presence of BMP4 (red
symbols in Figs. 2I–J). Pkig deletion further increases forskolin-induced alkaline
phosphatase activity assessed biochemically both in the absence and presence of BMP4 by
2.3 and 3.9-fold respectively and increases forskolin-independent alkaline phosphatase
activity both in the absence and presence of BMP4 by 4.3 and 4.9-fold respectively (blue
symbols in Fig. 2I). Staining of alkaline phosphatase activity confirms these results (lower
panel of Fig. 2I). Pkig deletion also increases mineralization in cultures continuously
stimulated with BMP4 by 6.4 and 1.6-fold respectively in the absence and presence of
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forskolin (3rd and 4th pairs of groups in Fig. 2J) and there was a trend towards increased
mineralization by the Pkig−/− MEFs in the absence of BMP4 (1st and 2nd pairs of groups in
Fig. 2J). These results collectively demonstrate that Pkig deletion substantially increases
osteoblast differentiation by MEFs.
Pkig deletion decreases adipocyte differentiation
Osteoblast and adipocyte differentiation are often regulated reciprocally but both lineages
are stimulated by PKA signaling (see Introduction for details). We therefore next asked
which of these mechanisms would predominate during adipogenesis when PKA signaling is
enhanced by Pkig deletion. In adipogenic medium, Pkig remains the dominant Pki family
member expressed in MEFs and Pkig deletion does not induce detectable compensatory
changes in the other Pki family members (Figs. 3A–C). As expected (19–22), induction of
PKA signaling with the phosphodiesterase inhibitor IBMX increases adipocyte
differentiation as assessed by measuring expression of both early and late adipogenic marker
genes (red symbols in Figs. 3D–E for early markers and in Figs. 3F–G for late markers) or
by staining for lipid accumulation with Oil Red O (red symbols in Fig. 3H). In contrast,
further enhancement of PKA signaling by Pkig deletion decreases IBMX-induced
expression of both the early and late adipogenic marker genes by 20–52% (blue symbols in
Figs. 3D–G). Moreover, Pkig deletion inhibits Oil Red O staining by 33% in the presence of
IBMX and indomethacin (last pair of groups in Fig. 3H) and there was a trend toward
inhibition by Pkig deletion in all other tested conditions (first three pairs of groups in Fig.
3H). Taken together, these results demonstrate that Pkig deletion decreases adipocyte
differentiation.
Pkig deletion simultaneously increases osteoblast differentiation and decreases adipocyte
differentiation
We next determined the effect of Pkig deletion on the simultaneous differentiation of
osteoblasts and adipocytes in mixed osteogenic/adipogenic medium. Pkig deletion increases
osteoblast differentiation as alkaline phosphatase activity, alkaline phosphatase staining, and
mineralization are increased (Figs. 4A–B). Pkig deletion decreases adipocyte differentiation
as assessed by Oil Red O staining by 30% on both day 4 and day 14 (Figs. 4C–D). Co-
staining for alkaline phosphatase and Oil Red O confirmed that the Pkig−/− MEFs are more
osteogenic (blue staining in Fig. 4E) and substantially less adipogenic (red staining in Fig.
4E) than the wild type MEFs. These images also confirm that the two lineages are distinct
from each other since almost no individual cells exhibited positive staining for both lineages
(Fig. 4E). In summary, the results with the mixed osteogenic/adipogenic medium are
consistent with the lineage-specific media reported above as Pkig deletion simultaneously
increases osteoblast differentiation and inhibits adipocyte differentiation and the magnitude
of the effect on osteoblast differentiation is larger than the effect on adipocyte
differentiation.
The effects of Pkig knockdown in murine and human MSCs are similar to the effects of
Pkig deletion in MEFs
To determine whether the results with MEFs are generalizable to mesenchymal precursor
cells, we first measured the effects of Pkig knockdown on mdMSCs cultured in mixed
osteogenic/adipogenic medium. Pkig is also the dominant Pki family member expressed in
the mdMSCs and Pkig knockdown does not induce detectable compensatory changes in the
other Pki family members (1st pair of groups in Figs. 5A–C). Pkig knockdown increases
expression of alkaline phosphatase and osteocalcin mRNAs by 2.2 and 1.6-fold compared to
control groups transfected with non-targeting siRNA duplexes (1st pair of groups in Figs.
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5D–E). Simultaneously, Pkig knockdown decreases expression of both the early and late
adipogenic marker genes by 30–37% (1st pair of groups in Figs. 5F–H).
To further determine whether the results are generalizable to human mesenchymal precursor
cells, we measured the effects of PKIG knockdown on hMSCs cultured in either osteogenic
or adipogenic medium. PKIG is also the dominant PKI family member expressed in the
hMSCs and PKIG knockdown does not induce detectable compensatory changes in other
PKI family members (1st pair of groups in Figs. 6A–C and Supplementary Figure 5). PKIG
knockdown increases expression of both alkaline phosphatase and osteocalcin mRNAs by
1.8-fold compared to control groups transfected with non-targeting siRNA duplexes (1st pair
of groups in Figs. 6D–E). In contrast, PKIG knockdown decreases mRNA expression of
PPARG by 38% and adiponectin by 46% (1st pair of groups in Figs. 6F–G). The effects of
PKIγ knockdown with mdMSCs and hMSCs therefore confirm the results with MEFs (Figs.
2–4) that Pkig deletion reciprocally increases osteoblast differentiation and decreases
adipocyte differentiation.
Reciprocal regulation of osteoblast and adipoctye differentiation by Pkig is mediated by
LIF
Lif expression is induced by PKA activation (Fig. 1E and references (41–43)) and LIF
increases osteoblast differentiation (33–38) and decreases adipocyte differentiation (34, 37,
39, 40). We therefore asked whether LIF mediates the effects of Pkig deletion. Consistent
with the results that Pkig deletion increases basal and forskolin-induced expression of Lif
mRNA (Fig. 1E), Pkig deletion also increases basal (2.7-fold), IBMX-induced (9.6-fold),
and forskolin-induced (7.6-fold) secretion of LIF protein (Fig. 7A). Concomitantly, Pkig
deletion increases basal (3.5-fold), IBMX-induced (3.9-fold), and forskolin-induced (5.9-
fold) alkaline phosphatase activity (Fig. 7B) as expected based on the results in Figures 2
and 4.
An antibody that neutralizes murine LIF was used to determine whether the effects of Pkig
deletion are mediated by LIF. Initial experiments showed that 0.3 ug/ml of the antibody
maximally inhibits osteoblast differentiation in Pkig−/− MEFs (Fig. 7C) and that
concentration was therefore used for all subsequent experiments. That concentration of
control immunoglobulin does not alter the effects of Pkig deletion on osteogenesis or
adipogenesis (compare 1st pair of groups in Figs. 7D–F with Figs. 2–4). In contrast, the LIF
antibody inhibits alkaline phosphatase activity, alkaline phosphatase staining, and
mineralization in the PKIg−/− MEFs (blue symbols and lower panels in Figs. 7D–E). The
LIF antibody also enhances lipid accumulation in Pkig−/− MEFs (blue symbols in Fig. 7F).
As a result, in the presence of the LIF antibody, there are no significant differences between
the wild type and the Pkig−/− MEFs in mineralization or lipid accumulation (last pair of
groups in Figs. 7E–F). These results demonstrate that the LIF antibody inhibits the effects of
Pkig deletion on both osteoblast and adipocyte differentiation by MEFs.
The anti-murine LIF antibody also inhibits the effects of Pkig knockdown on the mRNA
expression of the osteoblast marker genes by the mdMSCs (blue symbols in Figs. 5D–E). As
a result, in the presence of the LIF antibody, there are no significant differences between the
control and the Pkig knockdown groups in osteocalcin mRNA levels (2nd pair of group in
Fig. 5E). There are also no significant differences between the control and the Pkig
knockdown groups in levels of the adipocyte marker genes in the presence of the LIF
antibody (2nd pair of groups in Figs. 5F–H).
To determine whether LIF also mediates the effects of PKIG knockdown in human cells, we
used a monoclonal antibody that neutralizes human LIF. 10 ug/ml of that monoclonal
antibody was incubated with hMSCs based on the results in Fig. 7C and the manufacturer’s
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measurements of the relative potencies of the two antibodies. The anti-LIF monoclonal
antibody inhibits the effects of PKIG knockdown on the mRNA expression of osteoblast and
adipocyte marker genes (blue symbols in Figs. 6D–G). As a result, in the presence of the
LIF monoclonal antibody, there are no significant differences between the control and the
PKI knockdown groups in ALP and osteocalcin mRNA levels (2nd pair of groups in Figs.
6D–E). There are also no significant differences between the control and the PKI
knockdown hMSCs in levels of the adipocyte marker genes in the presence of the LIF
monoclonal antibody (2nd pair of groups in Figs. 6F–G). The mRNA expression results with
both mdMSCs and hMSCs therefore confirm and extend the biochemical and cytochemical
results with MEFs (Fig. 7) that the effects of Pkig deletion on the reciprocal regulation of
osteoblast and adipocyte differentiation are mediated by LIF.
Discussion
This study showed that activation of nuclear PKA by Pkig deletion or knockdown increases
osteoblast differentiation (right side of Fig. 7G). This occurred both in the presence of
exogenous activators of the PKA pathway (forskolin and IBMX) and in their absence. The
results in the absence of exogenous PKA activation likely reflect inhibition of basal PKA
activity by PKIγ. These results, together with our previous demonstration that PKIγ is a
primary mechanism that reduces the anti-apoptotic effects of PKA signaling in osteoblasts
(11), indicate that PKIγ is likely to be a major constraint on bone formation induced by
Gαs–coupled receptors. Downregulation of PKIγ may therefore provide a useful co-therapy
in combination with PKA agonists, such as intermittent PTH, for bone loss in conditions
such as osteoporosis. Downregulation of PKIγ may be particularly useful for the
approximately 20% patients who are unresponsive to therapy with intermittent PTH (64,
65). Downregulation of PKIγ may also be useful to enhance repair of bone defects by
mesenchymal precursor cells by programming their fate towards the osteoblastic lineage
(66–68). For example, our demonstration of relatively long term knockdown of Pkig may
provide a feasible approach to downregulate PKIγ ex vivo in mesenchymal precursor cells
prior to their implantation in bone defects. The primary limitation of our study with regard
to these potential clinical applications is that all of our experiments were conducted in vitro
and future studies will therefore be needed to assess the in vivo outcomes of Pkig deletion or
knockdown.
This study also showed that activation of nuclear PKA by Pkig deletion or knockdown
decreases adipocyte differentiation simultaneously with the increase of osteoblast
differentiation (left side of Fig. 7G). Thus, the reciprocal regulation between differentiation
of mesenchymal precursor cells into osteoblasts and adipocytes (27, 28) predominates over
the direct effects of PKA signaling to stimulate adipocyte differentiation (19–22). However,
the direct effects of PKA signaling (grey arrow in Fig. 7G) likely partially counterbalance
the reciprocal regulation, which may explain why Pkig deletion or knockdown has generally
more modest effects on adipoctye differentiation than on osteoblast differentiation.
Nonetheless, the decrease in adipocyte differentiation gives further credence to the
possibility that downregulation of PKIγ may be useful to enhance repair of bone defects,
especially in situations where adipogenesis impairs defect repair (67, 68).
This study further showed that the reciprocal regulation of osteoblast and adipocyte
differentiation by PKIγ is mediated, at least in part, by LIF (middle of Fig. 7G). Thus, Pkig
deletion increased PKA-induced Lif mRNA and LIF protein. Moreover, the effects of Pkig
deletion or knockdown on osteogenesis and adipogenesis were inhibited by two different
antibodies that respectively neutralize either murine or human LIF. Our results are consistent
with prior studies that LIF can increase osteoblast differentiation (33–38) and inhibit
adipogenesis (34, 37, 39, 40). Interestingly, the effects of LIF in those studies are primarily
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on early events in differentiation (34, 36–38), perhaps reflecting regulation of mesenchymal
lineage specification. It is likely that LIF acts together with other factors to mediate the
reciprocal regulation of osteogenesis and adipogenesis by PKIγ. Future studies will be
needed to identify those other factors and elucidate the details of how they interact with LIF
to reciprocally regulate osteoblast and adipocyte differentiation.
This study also confirmed our previous results (10, 11) that PKIγ reduces PKA signaling as
well as PKA-dependent phosphorylation of CREB and the resultant PKA-dependent
expression of rapidly induced mRNAs. We previously characterized c-fos, Lif, and IL6 as
immediate-early genes induced by PKA signaling (11, 42). However, the quantitative real-
time RT-PCR measurements of gene expression in this study distinguished between the
mRNAs. c-fos showed a typical immediate-early pattern of gene expression both in the wild
type and Pkig−/− MEFs. In contrast, Lif and IL6 mRNAs were induced and declined more
slowly and this was especially pronounced in the Pkig−/− MEFs.
In conclusion, our results show that Pkig reciprocally favors adipogenesis over osteogenesis
and, together with our previous studies (9–11), demonstrate that PKIγ is a major regulator of
PKA signaling in mesenchymal cells. PKA activity was recently shown to be regulated by
miRNA-27a or miRNA-155 that targets Pkia in hematopoietic cells (69–71). Intriguingly,
miRNA-155 can induce osteoblast differentiation (72). A transient increase in PKIβ level
was also shown to be required for neuronal differentiation in cell culture (73). Those results,
together with our studies and the earlier publications on PKIα (12, 13), represent
accumulating evidence that endogenous levels of the PKI family impact multiple cellular
processes by regulating PKA activity.
Supplementary Material
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PKIγ deletion substantially extends PKA signaling following stimulation with FSK. MEFs
from wild type (WT) and PKIγ−/− (KO) mice were incubated for 12 hours in osteogenic
medium (A) or for the indicated times (B–F) in osteogenic medium containing 1 uM
forskolin (FSK) or 0.1% DMSO as a vehicle control (C). mRNAs encoding members of the
PKI family (A) and PKA-dependent genes (D–F) were measured by quantitative real-time
RT-PCR, nuclear PKA activity was assessed biochemically (B), phosphorylation of CREB
and ATF-1 and total CREB were assessed by Western blotting (C). * denotes p < 0.05 as
compared with the indicated groups (A) or the WT groups at the same time points (B, D–F).
In (A), the horizontal bars represent the means of the 3 independent experiments indicated
by the individual symbols that represent means of 3 culture wells/group, each assayed in
triplicate. In (B, D–F), the symbols represent the mean ± SD of 3 independent experiments,
each consisting of 3 culture wells/group, each assayed in triplicate.
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PKIγ deletion substantially increases osteoblast differentiation. MEFs from wild type (WT)
and PKIγ−/− (KO) mice were incubated for the indicated times in osteogenic medium
supplemented with 1 uM forskolin (FSK) or 0.1% DMSO as a vehicle control in the
presence or absence of BMP-4. mRNAs encoding members of the PKI family (A–C) and
osteoblastic marker genes (D–H) were measured by quantitative real-time RT-PCR.
Osteoblast differentiation was also assessed by examining alkaline phosphatase (ALP)
biochemically and cytotochemically (I), and by Alizarin Red S staining of mineral (J), after
7 or 14 days, respectively, in osteogenic medium. * denotes p < 0.05 and NS denotes not
significant. The horizontal bars represent the means of the 3 (A–H, J) or 4 (I) independent
experiments indicated by the individual symbols that represent means of 3 culture wells/
group, each assayed in triplicate.
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PKIγ deletion decreases adipocyte differentiation. MEFs from wild type (WT) and PKIγ−/−
(KO) mice were incubated for the indicated times in repeated cycles of adipogenic induction
medium and maintenance medium as described in the Methods. mRNAs encoding members
of the PKI family (A–C) and adipocyte marker genes (D–G) were measured by quantitative
real-time RT-PCR. Adipocyte differentiation was also assessed by staining lipid
accumulation with Oil Red O after 14 days (H). * denotes p < 0.05 and NS denotes not
significant, The horizontal bars represent the means of the 3 independent experiments
indicated by the individual symbols that represent means of 3 culture wells/group, each
assayed in triplicate.
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PKIγ deletion simultaneously increases osteoblast differentiation and decreases adipocyte
differentiation in mixed osteogenic/adipogenic medium. MEFs from wild type (WT) and
PKIγ−/− (KO) mice were incubated for the indicated times in the mixed osteogenic/
adipogenic medium. Osteoblast differentiation was assessed by examining alkaline
phosphatase (ALP) biochemically and histochemically (A) and by Alizarin Red S staining of
mineral (B). Adipocyte differentiation was assessed by examining Oil Red O staining (C–
D). In (A–D), the horizontal bars represent the means of the 3 independent experiments
indicated by the individual symbols that represent means of 3 culture wells/group, each
assayed in triplicate. In (E), cultures were co-stained for alkaline phosphatase activity (blue)
and Oil Red O (red) after 4 days in the mixed osteogenic/adipogenic medium. Scale bars:
100 mm. * denotes p < 0.05.
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LIF mediates the effects of PKIγ knockdown on osteogenesis and adipogenesis in mdMSCs.
mdMSCs reverse transfected with non-targeting siRNA duplexes as a control (C) or siRNA
targeting PKIγ (KD) were incubated for 6 days in mixed osteogenic/adipogenic medium.
Culture medium was supplemented with 0.3 ug/ml of either control immunoglobulin (IgG)
or the anti-murine LIF Antibody (LIF Ab). mRNAs encoding members of the PKI family
(A–C), osteoblastic marker genes (D–E), and adipogenic marker genes (F–H) were
measured by quantitative real-time RT-PCR. Leptin mRNA was undetectable in all groups
(not shown). * denotes p < 0.05 and NS denotes not significant. In (A–H), the horizontal
bars represent the means of the 3 independent experiments indicated by the individual
symbols that represent means of 3 culture wells/group, each assayed in triplicate.
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LIF mediates the effects of PKIγ knockdown on osteogenesis and adipogenesis in hMSCs.
hMSCs reverse transfected with non-targeting siRNA duplexes as a control (C) or siRNA
targeting PKIγ (KD) were incubated for 6 days in osteogenic medium (A–E) or 3 cycles of
adipogenic induction medium (3 days) and adipogenic maintenance medium (2 days) (F–G).
Culture medium was supplemented with 10 ug/ml of either control immunoglobulin
(IgG2B) or the anti-human LIF monoclonal antibody (LIF MAb). mRNAs encoding
members of the PKI family (A–C), osteoblastic marker genes (D–E), and adipogenic marker
genes (F–G) were measured by quantitative real-time RT-PCR. C/EBPA and leptin mRNA
were undetectable in all groups with adipogenic media (not shown). * denotes p < 0.05 and
NS denotes not significant. Horizontal bars represent the means of the 3 independent
experiments indicated by the individual symbols that represent means of 3 culture wells/
group, each assayed in triplicate.
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LIF mediates the effects of PKIγ deletion on osteogenesis and adipogenesis in MEFs (G).
MEFs from wild type (WT) and PKIγ−/− (KO) mice were incubated for 1 day (A), 4 days
(B–D), or 14 days (E–F) in mixed osteogenic/adipogenic medium. Culture medium was
supplemented with 0.25 mM 3-isobutyl-1-methylxanthine (IBMX), 1 uM forskolin (FSK),
or 0.1% DMSO (C) as a vehicle control (A–B). Culture medium was supplemented with
IBMX plus the indicated concentrations of the neutralizing anti-murine LIF antibody (LIF
Ab) in (C) and 0.3 ug/ml of either control immunoglobulin (IgG) or the LIF antibody (LIF
Ab) in (D–F). LIF protein in the cell culture supernatants was measured by ELISA (A).
Osteoblast differentiation was assessed by examining alkaline phosphatase (ALP)
biochemically (B–D) and cytochemically (lower panel in D) and by Alizarin Red S staining
of mineral (E). Adipocyte differentiation was assessed by examining Oil Red O staining (F).
* denotes p < 0.05 and NS denotes not significant. In (A–B, D–F), the horizontal bars
represent the means of the 3 independent experiments indicated by the individual symbols
that represent means of 3 culture wells/group, each assayed in triplicate. In (C), the symbols
represent the mean ± SD of 3 independent experiments, each consisting of 3 culture wells/
group, each assayed in triplicate.
Chen et al. Page 21
Stem Cells. Author manuscript; available in PMC 2014 December 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
